Antiplatelet and anticoagulant drugs do not affect visual acuity in the comparing bevacizumab to ranibizumab in age-related macular degeneration (BRAMD) trial

Authors
Publication date
30 April 2017
Publisher

Abstract

Ophthalmic researc

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Leiden University Scholary Publications

    redirect
    oaioai:scholarlypublications.univ...
    Last time updated on 12/03/2021